Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Targeting Filamin A Reduces Macrophage Activity and Atherosclerosis.

Bandaru S, Ala C, Salimi R, Akula MK, Ekstrand M, Devarakonda S, Karlsson J, Van den Eynden J, Bergström G, Larsson E, Levin M, Borén J, Bergo MO, Akyürek LM.

Circulation. 2019 Apr 24. doi: 10.1161/CIRCULATIONAHA.119.039697. [Epub ahead of print]

PMID:
31014088
2.

13PPhosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways.

Umapathy G, Van den Eynden J, Cervantes-Madrid D, Szydzik J, Guan J, Palmer RH, Hallberg B.

Ann Oncol. 2019 Feb 1;30(Supplement_1). pii: mdz029.006. doi: 10.1093/annonc/mdz029.006. No abstract available.

PMID:
30810197
3.

Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers.

Elliott K, Boström M, Filges S, Lindberg M, Van den Eynden J, Ståhlberg A, Clausen AR, Larsson E.

PLoS Genet. 2018 Dec 26;14(12):e1007849. doi: 10.1371/journal.pgen.1007849. eCollection 2018 Dec.

4.

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways.

Van den Eynden J, Umapathy G, Ashouri A, Cervantes-Madrid D, Szydzik J, Ruuth K, Koster J, Larsson E, Guan J, Palmer RH, Hallberg B.

Sci Signal. 2018 Nov 20;11(557). pii: eaar5680. doi: 10.1126/scisignal.aar5680.

PMID:
30459281
5.

An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a.

Serviss JT, Andrews N, Van den Eynden J, Richter FC, Houtman M, Vesterlund M, Schwarzmueller L, Johnsson P, Larsson E, Grandér D, Pokrovskaja Tamm K.

Cell Death Dis. 2018 Jul 3;9(7):736. doi: 10.1038/s41419-018-0777-5.

6.

Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib.

Guan J, Fransson S, Siaw JT, Treis D, Van den Eynden J, Chand D, Umapathy G, Ruuth K, Svenberg P, Wessman S, Shamikh A, Jacobsson H, Gordon L, Stenman J, Svensson PJ, Hansson M, Larsson E, Martinsson T, Palmer RH, Kogner P, Hallberg B.

Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4). pii: a002550. doi: 10.1101/mcs.a002550. Print 2018 Aug.

7.

The genetic structure of the Belgian population.

Van den Eynden J, Descamps T, Delporte E, Roosens NHC, De Keersmaecker SCJ, De Wit V, Vermeesch JR, Goetghebeur E, Tafforeau J, Demarest S, Van den Bulcke M, Van Oyen H.

Hum Genomics. 2018 Feb 2;12(1):6. doi: 10.1186/s40246-018-0136-8.

8.

Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events.

Ashouri A, Sayin VI, Van den Eynden J, Singh SX, Papagiannakopoulos T, Larsson E.

Nat Commun. 2016 Oct 25;7:13197. doi: 10.1038/ncomms13197.

9.

Mutational Signatures Are Critical for Proper Estimation of Purifying Selection Pressures in Cancer Somatic Mutation Data When Using the dN/dS Metric.

Van den Eynden J, Larsson E.

Front Genet. 2017 Jun 8;8:74. doi: 10.3389/fgene.2017.00074. eCollection 2017.

10.

Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature.

Fredriksson NJ, Elliott K, Filges S, Van den Eynden J, Ståhlberg A, Larsson E.

PLoS Genet. 2017 May 10;13(5):e1006773. doi: 10.1371/journal.pgen.1006773. eCollection 2017 May.

11.

Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution.

Van den Eynden J, Basu S, Larsson E.

PLoS Genet. 2016 Dec 27;12(12):e1006506. doi: 10.1371/journal.pgen.1006506. eCollection 2016 Dec.

12.

Simultaneous discovery of cancer subtypes and subtype features by molecular data integration.

Le Van T, van Leeuwen M, Carolina Fierro A, De Maeyer D, Van den Eynden J, Verbeke L, De Raedt L, Marchal K, Nijssen S.

Bioinformatics. 2016 Sep 1;32(17):i445-i454. doi: 10.1093/bioinformatics/btw434.

PMID:
27587661
13.

Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.

Verbeke LP, Van den Eynden J, Fierro AC, Demeester P, Fostier J, Marchal K.

PLoS One. 2015 Jul 28;10(7):e0133503. doi: 10.1371/journal.pone.0133503. eCollection 2015.

14.

SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.

Van den Eynden J, Fierro AC, Verbeke LP, Marchal K.

BMC Bioinformatics. 2015 Apr 23;16:125. doi: 10.1186/s12859-015-0555-7.

15.

Glycine enhances microglial intracellular calcium signaling. A role for sodium-coupled neutral amino acid transporters.

Van den Eynden J, Notelaers K, Brône B, Janssen D, Nelissen K, Sahebali S, Smolders I, Hellings N, Steels P, Rigo JM.

Pflugers Arch. 2011 Apr;461(4):481-91. doi: 10.1007/s00424-011-0939-0. Epub 2011 Feb 25.

PMID:
21350800
16.

The inhibitory neurotransmitter glycine modulates macrophage activity by activation of neutral amino acid transporters.

Carmans S, Hendriks JJ, Thewissen K, Van den Eynden J, Stinissen P, Rigo JM, Hellings N.

J Neurosci Res. 2010 Aug 15;88(11):2420-30. doi: 10.1002/jnr.22395.

PMID:
20623529
17.

Glycine and glycine receptor signalling in non-neuronal cells.

Van den Eynden J, Ali SS, Horwood N, Carmans S, Brône B, Hellings N, Steels P, Harvey RJ, Rigo JM.

Front Mol Neurosci. 2009 Aug 20;2:9. doi: 10.3389/neuro.02.009.2009. eCollection 2009.

18.

A highly reliable and budget-friendly Peltier-cooled camera for biological fluorescence imaging microscopy.

Jolling K, Vandeven M, Van den Eynden J, Ameloot M, Van Kerkhove E.

J Microsc. 2007 Dec;228(Pt 3):264-71.

19.

Dorsal unpaired median neurons of locusta migratoria express ivermectin- and fipronil-sensitive glutamate-gated chloride channels.

Janssen D, Derst C, Buckinx R, Van den Eynden J, Rigo JM, Van Kerkhove E.

J Neurophysiol. 2007 Apr;97(4):2642-50. Epub 2007 Jan 31.

20.

Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET.

Baete K, Nuyts J, Van Laere K, Van Paesschen W, Ceyssens S, De Ceuninck L, Gheysens O, Kelles A, Van den Eynden J, Suetens P, Dupont P.

Neuroimage. 2004 Sep;23(1):305-17.

PMID:
15325378
21.

Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.

Van Laere K, De Ceuninck L, Dom R, Van den Eynden J, Vanbilloen H, Cleynhens J, Dupont P, Bormans G, Verbruggen A, Mortelmans L.

Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1119-27. Epub 2004 Apr 3.

PMID:
15064872

Supplemental Content

Loading ...
Support Center